FDA: New Variants Mean COVID-19 Vaccines, Tests May Need Tweaking
Agency offers recommendations for companies seeking to modify already-approved vaccines, medicines, and tests so they can remain effective
Prevalence of Multiple Chronic Conditions Up Among Veterans
Prevalence of MCC remained higher for male, female veterans after stratification by age and adjustment for sociodemographics
FDA Warns Not to Rely on Pulse Oximetry for Diagnosis, Treatment Decisions
Safety communication follows NEJM study showing risk for inaccuracy with use of pulse oximeters in those with dark skin pigmentation
Transplant Recipient Dies After Receiving COVID-19-Infected Lungs
Surgeon who handled the donor lungs also became infected and fell ill but recovered
COVID-19 Vaccines Adapted to Fight Variants Will Not Require Long Clinical Trials: FDA
Most makers of approved COVID-19 vaccines have said they plan to adapt their vaccines to tackle variants
COVID-19 Vaccine Efficacy Higher With Three-Month Interval Between Doses
For ChAdOx1 nCoV-19 Oxford vaccine, three-month interval results in higher efficacy than six-week interval
Listeria Outbreak Spurs Recall of Queso Fresco Cheeses
There have been seven illnesses reported so far; all patients were hospitalized
All British Adults Should Have First COVID-19 Shot by July 31: Government
Announcement made as government prepares a 'cautious' reopening plan
CDC Report Shows No Evidence of Unexpected Adverse Events With COVID-19 Vaccines
Findings from the first month show no unexpected adverse events, with 6,994 adverse events and >90 percent classified as nonserious
SARS-CoV-2, COVID-19 Rates Decreased After One Vaccine Dose
Study among health care workers shows reductions in SARS-CoV-2 infection rates one to 14, 15 to 28 days after first dose of the BNT162b2 COVID-19 vaccine
